The present study was aimed to evaluate the potential of the ethanolic extract of Terminalia chebula in mitigating breast cancer, which is crippling several women around the world. We have identified the phytochemicals and confirmed by GC-MS studies. Further investigations were carried out to determine the anticancer activity of the extract invitro by MTT assay and antioxidant activity by Reducing Power assay. The results obtained were found to be effective in authenticating the pharmacological nature of T. chebula. In this effort, we have surfaced with a promising potential therapeutic agent as a part of our research work. Our observations are suggestive of the fact that this extract could ably serve as a drug candidate for further research, being a harbinger of hope to cancer patients